Position Statements

INFORMATION DISCLAIMERS

Pertaining in particular to the Simethicone Position Statement

This Position Statement is based on a careful assessment of the current literature regarding the benefits and potential risks of the use of simethicone in endoscopy. Each endoscopy facility should make its own determination regarding the use of simethicone during endoscopic procedures and the route of administration. Endoscopy facilities should have regard to any information, research or other material which may have been published or become available subsequently and reassess their position accordingly.

It is not implied that the Statement is applicable in all cases, or in any particular case, but is a general policy document that may provide guidance for users. Users should use their own judgment and consider the particular circumstances of each case. The user should have regard to any information, research or other material which may have been published or become available subsequently.

This Statement is current at the time at which the endorsement is expressed. The Statement may be reviewed and updated from time to time. GESA does not necessarily take responsibility for reviewing its endorsements and it is the responsibility of the user to ensure that they have obtained the current version or are aware of more recent or more appropriate Statements.

 

Pertaining to all Position Statements in General

The Statements and Guidelines expressed as endorsed on this website have been endorsed as general documents, appropriate having regard to the general circumstances to which they apply at the time of their endorsement. It is the responsibility of the user to have express regard to the particular circumstances of each case, and the application of the Statements and Guidelines in each case.

GESA’s endorsement is applicable at the time at which the endorsement is expressed.  The Statements and Guidelines, developed by third parties, may be reviewed and updated from time to time.  GESA does not necessarily take responsibility for reviewing its endorsements, and it is the responsibility of the user to ensure that they have obtained the current version, or are aware of more recent or more appropriate Statements and Guidelines.

The Statements and Guidelines have been prepared having regard to the information available at the time of their preparation (and applicable at the time of GESA’s endorsement), and the user should therefore have regard to any information, research or other material which may have been published or become available subsequently.  GESA takes no responsibility in this case.

Whilst GESA endeavours to ensure that professional documents are as current as possible at the time of their endorsement, it takes no responsibility for matters arising from changed circumstances or information or material which may have become available subsequently.

The endorsement of GESA does not imply that the Statements and Guidelines are applicable in all cases, or in any particular case, but are general policy documents that may provide guidance for users.  Users should use their own judgment and consider the particular circumstances of each case.

 

Position Statement on Simethicone Use During Gastrointestinal Endoscopy  - 2019

Position Statement on Infection Control in Endoscopy Guidelines  - August 2016

Position Statement on Faecal Microbiota Transplant (FMT)  - September 2015

Position Statement on Biosimilars Substitution - GESA & AIBDA June 2015

Position Statement on Nurse Endoscopy - January 2015

Position Statement on Prescribing of Interferon-Free Treatment Regimes for Chronic HCV Infection - GESA & ALA June 2015